"Analysis of human BDCA3+ DC interactions with tumors, NK and CD8 T cells" and 18-months POST-DOCTORAL POSITION OPEN IN TUMOUR IMMUNOLOGY IN LYON, FRANCE
"Validation of anti-ICOS antibody as a drug candidate for anti-tumor immunotherapy through neutralization of regulatory T cell suppressive activity "
If you are interested, you should address your CV and contact information of 3 referees via e-mail to Dr. Jenny VALLADEAU-GUILEMOND at jenny.valladeau-guilemond@
Sincerely yours,
Jenny VALLADEAU-GUILEMOND, PhD
Christophe CAUX and Jean Yves BLAY , Co-heads
Centre Léon Bérard- UMR INSERM 1052-CNRS 5286
Centre de recherche en Cancérologie de Lyon
Dép. Immunité Microenvironnement et Virus
Equipe Ciblage thérapeutique de la tumeur et de son environnement immunitaire
Cheney D-3éme Et.
28 rue Laënnec, 69008 LYON
Tel (+ 33) 4 78 78 29 64
Fax (+33) 4 78 78 27 20
No comments:
Post a Comment